ISO Standards Context of the organisation

Context of the Organization

(ISO 9001:2015 – Clause 4.1 to 4.4)

1. Purpose

To identify and understand the internal and external issues, interested parties, and processes that influence the Quality Management System (QMS) and the organization's ability to consistently supply quality Active Pharmaceutical Ingredients (APIs).

2. Organization Profile

The organization manufactures Active Pharmaceutical Ingredients (APIs) for domestic and international markets. The Quality Management System covers product development support, procurement, manufacturing, quality control, quality assurance, warehousing, dispatch, engineering, and supporting functions.

3. Internal Issues

• Experienced workforce and technical expertise.
• cGMP-compliant manufacturing facilities.
• Qualified Quality Control and Quality Assurance laboratories.
• Equipment qualification and preventive maintenance.
• Data integrity practices.
• Financial resources and business strategy.
• Organizational culture focused on quality and compliance.
• Training and competency of personnel.

4. External Issues

• Regulatory requirements (US FDA, EMA, MHRA, PMDA, WHO-GMP, CDSCO, etc.).
• Customer expectations and contractual requirements.
• Availability and quality of raw materials.
• Global supply chain challenges.
• Technological developments.
• Environmental and sustainability requirements.
• Economic conditions and market competition.
• Occupational health and safety regulations.

5. Interested Parties and Their Needs

Interested Party	Needs and Expectations
Customers	High-quality APIs, on-time delivery, regulatory compliance
Regulatory Authorities	Compliance with applicable GMP regulations
Employees	Safe workplace, training, career development
Suppliers	Clear specifications, timely payments, long-term relationships
Shareholders	Sustainable growth and profitability
Local Community	Environmental protection and responsible operations

6. Scope of the Quality Management System

The Quality Management System applies to the manufacture, testing, release, storage, and distribution of Active Pharmaceutical Ingredients manufactured at the site.

7. QMS Processes

• Management Review
• Quality Assurance
• Quality Control
• Production
• Warehouse
• Procurement
• Engineering & Maintenance
• Validation & Qualification
• Calibration
• Training
• Change Control
• Deviation Management
• CAPA
• Risk Management
• Internal Audit
• Supplier Qualification
• Customer Complaint Handling
• Document Control

8. Risks and Opportunities

Risks

• Regulatory observations.
• Supplier quality failures.
• Equipment breakdown.
• Data integrity issues.
• Cross-contamination.
• Skilled manpower shortage.

Opportunities

• Process automation.
• Digital quality systems.
• Employee competency development.
• Continuous improvement initiatives.
• Energy conservation and cost reduction.
• Expansion into regulated markets.

9. Monitoring and Review

The context of the organization shall be reviewed during:

• Management Review Meetings.
• Annual Quality Review.
• Strategic Business Review.
• Regulatory changes.
• Significant organizational or business changes.

10. Responsibility

The Head of Quality, along with Top Management, is responsible for establishing, reviewing, and maintaining the Context of the Organization and ensuring its continued suitability.